Mednext Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 12 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 16.59 Cr
- Satisfied Charges ₹ 10.01 Cr
- Revenue Growth 60.61%
- Profit Growth 116.78%
- Ebitda 78.24%
- Net Worth 77.84%
- Total Assets 37.45%
About Mednext Biotech
Mednext Biotech Limited (MBL) is a leading Public Limited Indian Non-Government Company incorporated in India on 17 August 2012 and has a history of 12 years and five months. Its registered office is in Udaipur, Rajasthan, India.
The Corporate was formerly known as Mednext Biotech Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹16.59 Cr. The company has closed loans amounting to ₹10.01 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anil Vyas, Neelam Vyas, Sunil Chittora, and One other member serve as directors at the Company.
Company Details
- Location
Udaipur, Rajasthan, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24232RJ2012PLC039813
- Company No.
039813
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Aug 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Mednext Biotech?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Vyas  | Director | 10-Oct-2017 | Current |
| Neelam Vyas | Director | 17-Aug-2012 | Current |
| Sunil Chittora | Director | 03-Feb-2018 | Current |
| Pankaj Vyas | Director | Current |
Financial Performance of Mednext Biotech.
Mednext Biotech Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 60.61% increase. The company also saw a substantial improvement in profitability, with a 116.78% increase in profit. The company's net worth Soared by an impressive increase of 77.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mednext Biotech?
In 2023, Mednext Biotech had a promoter holding of 99.21% and a public holding of 0.79%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mednext Pharma Private LimitedAnil Vyas and Neelam Vyas are mutual person
Alice Pharma Private LimitedAnil Vyas and Neelam Vyas are mutual person
- Alice Pharma (Mumbai) Private Limited
Neelam Vyas is a mutual person
Ceza Formulations Private LimitedAnil Vyas is a mutual person
- Tirtham Hospitality Private Limited
Anil Vyas and Neelam Vyas are mutual person
Charges (Loans)
₹16.59 Cr
₹10.01 Cr
Charges Breakdown by Lending Institutions
- Others : 16.59 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Mar 2022 | Others | ₹15.99 Cr | Open |
| 16 Mar 2022 | Others | ₹6.00 M | Open |
| 20 Jul 2020 | Others | ₹6.50 M | Satisfied |
| 01 Jun 2019 | Others | ₹5.61 Cr | Satisfied |
| 31 Mar 2018 | Others | ₹3.75 Cr | Satisfied |
How Many Employees Work at Mednext Biotech?
Mednext Biotech has a workforce of 33 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mednext Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mednext Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
